Literature DB >> 17473220

Progression to type 2 diabetes characterized by moderate then rapid glucose increases.

Clinton C Mason1, Robert L Hanson, William C Knowler.   

Abstract

OBJECTIVE: The transition of an individual from normoglycemia to diabetes has generally been thought to involve either moderate or rapid changes in glucose over time, although few studies have analyzed these changes. We sought to determine whether a general pattern of glucose change exists in most individuals who become diabetic. RESEARCH DESIGN AND METHODS: We examined longitudinal data from Pima Indians who developed diabetes after several biennial examinations to characterize changes in 2-h plasma glucose. A distinct pattern of glucose change was apparent in the time course of most individuals, an initial linear trend followed by a steeper rise in glucose values. A model consisting of additive linear and exponential functions was hypothesized to account for this pattern and was tested for goodness of fit on 55 individuals who became diabetic after at least 10 previous examinations.
RESULTS: The combined linear and exponential model provided a significantly better fit than linear or exponential models alone in 40 of the 55 cases (P < 10(-38)). Using this model, the timeframe over which glucose values rose suddenly was estimated, having a median time to onset of <4.5 years from the time at which the exponential effect had contributed a modest increase of 10 mg/dl to the initial linear trend.
CONCLUSIONS: We conclude that there are two distinct processes affecting glucose levels in most individuals who progress to type 2 diabetes and that the rapid glucose rise identified in these people may be an important period for physiologic and preventive research.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17473220     DOI: 10.2337/db07-0053

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  30 in total

1.  Strategies for preventing type 2 diabetes: an update for clinicians.

Authors:  Kaivan Khavandi; Halima Amer; Bashar Ibrahim; Jack Brownrigg
Journal:  Ther Adv Chronic Dis       Date:  2013-09       Impact factor: 5.091

2.  Reducing the prevalence of dysglycemia: is the time ripe to test the effectiveness of intervention in high-risk individuals with elevated 1 h post-load glucose levels?

Authors:  Michael Bergman; Ram Jagannathan; Martin Buysschaert; Jose Luis Medina; Mary Ann Sevick; Karin Katz; Brenda Dorcely; Jesse Roth; Angela Chetrit; Rachel Dankner
Journal:  Endocrine       Date:  2017-01-25       Impact factor: 3.633

3.  Type 2 diabetes: one disease, many pathways.

Authors:  Joon Ha; Arthur Sherman
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-07-14       Impact factor: 4.310

Review 4.  What should governments be doing to prevent diabetes throughout the life course?

Authors:  Patrick Timpel; Lorenz Harst; Doreen Reifegerste; Susann Weihrauch-Blüher; Peter E H Schwarz
Journal:  Diabetologia       Date:  2019-08-27       Impact factor: 10.122

5.  Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study.

Authors:  E Ferrannini; A Natali; E Muscelli; P M Nilsson; A Golay; M Laakso; H Beck-Nielsen; A Mari
Journal:  Diabetologia       Date:  2011-03-22       Impact factor: 10.122

6.  Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study.

Authors:  Adam G Tabák; Markus Jokela; Tasnime N Akbaraly; Eric J Brunner; Mika Kivimäki; Daniel R Witte
Journal:  Lancet       Date:  2009-06-08       Impact factor: 79.321

7.  Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset.

Authors:  Ele Ferrannini; Andrea Mari; Valentina Nofrate; Jay M Sosenko; Jay S Skyler
Journal:  Diabetes       Date:  2009-12-22       Impact factor: 9.461

8.  Racial/ethnic differences in association of fasting glucose-associated genomic loci with fasting glucose, HOMA-B, and impaired fasting glucose in the U.S. adult population.

Authors:  Quanhe Yang; Tiebin Liu; Peter Shrader; Ajay Yesupriya; Man-huei Chang; Nicole F Dowling; Renée M Ned; Josée Dupuis; Jose C Florez; Muin J Khoury; James B Meigs
Journal:  Diabetes Care       Date:  2010-08-30       Impact factor: 19.112

9.  Pharmacogenetics of Anti-Diabetes Drugs.

Authors:  Johanna K Distefano; Richard M Watanabe
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-01

10.  Diabetes care in black and white veterans in the southeastern U.S.

Authors:  Jennifer G Twombly; Qi Long; Ming Zhu; Peter W F Wilson; K M Venkat Narayan; Lisa-Ann Fraser; Brian C Webber; Lawrence S Phillips
Journal:  Diabetes Care       Date:  2010-01-26       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.